Stockscreener 앱 받기
14.72
3.65%
0.2101
전일 마감가:
$14.51
열려 있는:
$14.43
하루 거래량:
10,702
Relative Volume:
0.07
시가총액:
$57.49M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-15.86%
1개월 성능:
-12.71%
6개월 성능:
+116.71%
1년 성능:
+223.44%
1일 변동 폭
$14.43
$15.19
1주일 범위
$14.43
$18.12
52주 변동 폭
$2.70
$38.25
Quantum Biopharma Ltd Stock (QNTM) Company Profile
QNTM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
QNTM
Quantum Biopharma Ltd
|
15.06 | 55.38M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.74 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.18 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.12 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.26 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
329.04 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Quantum Biopharma Ltd 주식(QNTM)의 최신 뉴스
Will Quantum BioPharma Ltd. stock sustain high P E ratios2025 Big Picture & Free High Return Stock Watch Alerts - newser.com
Can Quantum BioPharma Ltd. stock beat analyst upgrades2025 Market Outlook & Verified Momentum Stock Alerts - newser.com
Building trade automation scripts for Quantum BioPharma Ltd.Weekly Stock Summary & Consistent Growth Equity Picks - newser.com
How to recover losses in Quantum BioPharma Ltd. stockPortfolio Profit Report & Long Hold Capital Preservation Tips - newser.com
ME Therapeutics Added to CSE25 Index - Investing News Network
How to track smart money flows in Quantum BioPharma Ltd.Fed Meeting & Weekly High Potential Stock Alerts - newser.com
Quantum Biopharma's (QNTM) Sell (E+) Rating Reaffirmed at Weiss Ratings - MarketBeat
Quantum BioPharma Ltd. Investigated for Securities Fraud ViolationsContact the DJS Law Group to Discuss Your Rights – QNTM - MarketScreener
QNTM Investors Have Opportunity to Join Quantum BioPharma Ltd. Fraud Investigation with the Schall Law Firm - The AI Journal
Quantum BioPharma offers $7 million reward for stock manipulation evidence By Investing.com - Investing.com Nigeria
Quantum BioPharma Launches $7 Million Whistleblower Program Targeting Stock Manipulation - citybuzz
About Us - FinancialContent
Quantum BioPharma (QNTM) Offers $7M for Solid Evidence of Stock Manipulation - GuruFocus
Quantum BioPharma (QNTM) Introduces $7M Whistleblower Reward Pro - GuruFocus
Quantum BioPharma Launches Whistleblower Reward Amid Stock Manipulation Lawsuit - TipRanks
Quantum BioPharma offers $7 million reward for stock manipulation evidence - Investing.com India
Quantum BioPharma Ltd. Introduces Whistleblower Policy with Up to $7 Million Reward for Reporting Stock Manipulation Evidence - Quiver Quantitative
Quantum BioPharma Pioneers Digitally Integrated Biotech Model with Neuroprotective MS Treatment - citybuzz
Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View - ACCESS Newswire
7% royalty until $250M — Quantum BioPharma secures Upstream dual listing to modernize market access - Stock Titan
From Lab Bench to Blockchain: How Biotech is Reinventing Funding - The Globe and Mail
Is Quantum BioPharma Ltd. (0K91) stock at risk of policy regulation2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com
Top Cannabis Stocks To ConsiderOctober 2nd - MarketBeat
Real time alert setup for Quantum BioPharma Ltd. performanceWeekly Risk Report & Consistent Income Trade Recommendations - newser.com
Why Quantum BioPharma Ltd. stock could rally in 2025Rate Hike & Daily Stock Trend Reports - newser.com
What machine learning models say about Quantum BioPharma Ltd.2025 Market Outlook & Capital Efficient Trade Techniques - newser.com
Evaluating Quantum BioPharma Ltd. with trendline analysisEarnings Overview Summary & Long-Term Safe Investment Plans - newser.com
Cannabis Stocks To Watch TodayOctober 4th - MarketBeat
Quantum BioPharma Sets Record Date for Litigation-Linked CVR Distribution - citybuzz
Quantum BioPharma Sets Record Date for Special Dividend Linked to Litigation Proceeds - MSN
Quantum BioPharma sets October 27 record date for litigation-linked CVRs - Investing.com Nigeria
Quantum BioPharma (QNTM) Sets Record Date for Contingent Value R - GuruFocus
Quantum BioPharma sets October 27 record date for litigation-linked CVRs By Investing.com - Investing.com South Africa
Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case - The Manila Times
Upcoming Events - FinancialContent
Combining machine learning predictions for Quantum BioPharma Ltd.July 2025 Recap & Long-Term Safe Investment Ideas - newser.com
Analyzing recovery setups for Quantum BioPharma Ltd. investorsQuarterly Portfolio Report & Consistent Return Strategy Ideas - newser.com
Quantum BioPharma receives final toxicity reports for MS drug candidate By Investing.com - Investing.com Nigeria
Quantum BioPharma Advances Multiple Sclerosis Drug Toward Clinical Trials with Final Toxicity Reports - citybuzz
Quantum BioPharma Advances with Key Studies for Multiple Scleros - GuruFocus
Quantum BioPharma receives final toxicity reports for MS drug candidate - Investing.com India
Quantum Biopharma Brief: Says Received Final Reports for Two Key Studies of its "Potential Breakthrough" Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial - MarketScreener
Quantum BioPharma Advances Lucid-MS with Key Study Reports - TipRanks
Quantum Biopharma Ltd (QNTM) 재무 분석
Quantum Biopharma Ltd (QNTM)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.21%
2.95%
자본화:
|
볼륨(24시간):